Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 4/20 | 0.39 |
| ▸ | LOX | P28300 | 1/20 | 0.39 |
| ▸ | LOXL3 | P58215 | 1/20 | 0.39 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.34 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6548307 | 0.86 | ALDH1A1 (0.44) | ALDH1A1TDP1TSHRLOXLOXL3 | |
| SCHEMBL11170147 | 0.86 | ALDH1A1 (0.44) | ALDH1A1TDP1TSHRLOXLOXL3 | |
| SCHEMBL18665263 | 0.85 | — | — | |
| SCHEMBL14775080 | 0.85 | TSHR (0.39) | ALDH1A1TDP1TSHRLOXLOXL3 | |
| SCHEMBL19257635 | 0.81 | — | — | |
| SCHEMBL10107013 | 0.79 | TSHR (0.62) | ALDH1A1TDP1TSHRMAPTHSD17B10 | |
| SCHEMBL361130 | 0.77 | — | — | |
| SCHEMBL97811 | 0.75 | MCL1 (0.41) | ALDH1A1TSHRMCL1 | |
| SCHEMBL31506420 | 0.74 | ALDH1A1 (0.33) | ALDH1A1TDP1TSHRESR1MAPT | |
| SCHEMBL2991686 | 0.74 | ALDH1A1 (0.47) | ALDH1A1TDP1TSHRLOXLOXL3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009156622-A1 | ABSORBING SOLUTION CONTAINING A SULPHURATED ORGANIC DEGRADATION INHIBITOR AND METHOD FOR LIMITING THE DEGRADATION OF AN ABSORBING SOLUTION | IFP (FR) | 2009-12-30 | — | — | WO | claimed |
| JP-7291921-A | — | — | None | — | — | JP | disclosed |
| EP-4658664-A1 | CAP ANALOGS WITH 5'-TERMINAL ACYCLIC GUANOSINE DERIVATIVE | CureVac SE (DE) | 2025-12-10 | — | — | EP | disclosed |
| WO-2024160895-A1 | CAP ANALOGS WITH 5'-TERMINAL ACYCLIC GUANOSINE DERIVATIVE | CureVac SE (DE) | 2024-08-08 | — | — | WO | disclosed |
| US-20240229026-A1 | CHIRAL CONTROL | WAVE LIFE SCIENCES LTD. (SG) | 2024-07-11 | — | — | US | disclosed |
| WO-2023224190-A1 | ADDITIVE, ELECTROLYTE COMPRISING SAME FOR LITHIUM SECONDARY BATTERY, POSITIVE ELECTRODE, AND LITHIUM SECONDARY BATTERY | 삼성에스디아이 주식회사 | 2023-11-23 | — | — | WO | disclosed |
| US-11718638-B2 | Compounds, compositions and methods for synthesis | WAVE LIFE SCIENCES LTD. (SG) | 2023-08-08 | — | — | US | disclosed |
| EP-4219516-A2 | CHIRAL CONTROL | Wave Life Sciences Ltd. (SG) | 2023-08-02 | — | — | EP | disclosed |
| US-11643657-B2 | Chiral control | WAVE LIFE SCIENCES LTD. (SG) | 2023-05-09 | — | — | US | disclosed |
| US-11634710-B2 | Oligonucleotide compositions and methods thereof | WAVE LIFE SCIENCES LTD. (SG) | 2023-04-25 | — | — | US | disclosed |
| JP-H07291921-A | PREPARATION OF 3-MERCAPTOPROPIONITRILE AND 3-MERCAPTOPROPIONIC ACID | HAMPSHIRE CHEM CORP | 1995-11-07 | — | — | JP | disclosed |
| EP-0677512-A1 | Process for the preparation of 3-mercapto-propion-nitrile and 3-mercapto-propionic acid | HAMPSHIRE CHEMICAL CORPORATION (US) | 1995-10-18 | — | — | EP | disclosed |
| US-5391820-A | Preparation of 3-mercaptopropionitrile and 3-mercaptopropionic acid | HAMPSHIRE CHEMICAL CORP. (US) | 1995-02-21 | — | — | US | disclosed |
| EP-0235452-B1 | ORGANIC COMPOUNDS AND THEIR PHARMACEUTICAL USE | LILLY INDUSTRIES LIMITED (GB) | 1992-03-18 | — | — | EP | disclosed |
| US-4845110-A | Organic compounds and their pharmaceutical use | LILLY INDUSTRIES LIMITED (GB) | 1989-07-04 | — | — | US | disclosed |
| EP-0235452-A2 | Organic compounds and their pharmaceutical use | LILLY INDUSTRIES LIMITED (GB) | 1987-09-09 | — | — | EP | disclosed |
| US-4167575-A | BIOCIDES | ROHM AND HAAS COMPANY (US) | 1979-09-11 | — | — | US | disclosed |
| US-4082808-A | ANTIOXIDANTS, INTERMEDIATES FOR POLYESTERS, POLYCARBONATES, EPOXY RESINS | GENERAL ELECTRIC COMPANY (US) | 1978-04-04 | — | — | US | disclosed |
| US-4053479-A | BIOCIDES | ROHM AND HAAS COMPANY (US) | 1977-10-11 | — | — | US | disclosed |
| US-3957808-A | BIOCIDES | ROHM AND HAAS COMPANY (US) | 1976-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11718638-B2 | Compounds, compositions and methods for synthesis | ALKBH1, DUT, RNGTT | ALDH1A1 2134/4885TDP1 366/4885TSHR 3918/4885 |
| US-20240229026-A1 | CHIRAL CONTROL | RNGTT, POLI, NSUN3 | ALDH1A1 2867/4885TDP1 924/4885TSHR 3259/4885 |
| US-11643657-B2 | Chiral control | RNGTT, POLI, NSUN3 | ALDH1A1 2867/4885TDP1 924/4885TSHR 3259/4885 |
| US-11634710-B2 | Oligonucleotide compositions and methods thereof | RBM17, HNRNPA2B1, HNRNPA1 | ALDH1A1 3613/4885TDP1 214/4885TSHR 3181/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.